Janux Therapeutics Inc Capital Reinvestment Ratio

Latest as of March 2021: 0.03x

Janux Therapeutics Inc capital reinvestment ratio. Janux Therapeutics Inc (JANX) has a Capital Reinvestment Ratio of 0.03x as of March 2021, meaning it reinvests 0% of its operating cash flow ($5.56 Million) in capital expenditures ($153.00K). See JANX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$5.56 Million

USD

Capital Expenditures

$153.00K

USD

Data as of

Mar 2021

Most recent filing

Janux Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Janux Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see JANX operating cash flow.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow